| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |